English Abstract
Journal Article
Add like
Add dislike
Add to saved papers

[Effects of mesenchymal stem cells on angiogenesis of cervical cancer HeLa cancer cell line HeLa in vivo].

OBJECTIVE: To explore the effects of bone marrow-derived mesenchymal stem cell (MSC) on angiogenesis of cervical cancer cell.

METHODS: MSCs from umbilical cord were mixed with cervical cancer cell line HeLa cells and subcutaneously plated in armpit area of nude mice to examine the in vivo tumor growth. Micro-vessel density (MVD) in tumor tissue was examined by CD34 immunohistochemical staining. Enzyme-linked immunosorbent assay (ELISA) and real-time polymerase chain reaction (PCR) were employed to detect the expression of proangiogenesis factors.

RESULTS: MSC could effectively promote the cervical cancer growth in vivo as compared with controls (P<0.05). The immunohistochemical results of CD34 staining showed that MVD of cervical cancer was higher in MSC group than that in control group (P<0.05). And there was a higher expression of vascular endothelial growth factor (VEGF) in MSC than controls.

CONCLUSION: MSC promotes the in vivo angiogenesis of cervical cancer cell line by VEGF production.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app